Venu Chalasani

Dr. Venu Chalasani is a Urological Surgeon and Clinical Senior Lecturer at the Northern Clinical School, University of Sydney. His research focuses on urological cancers, particularly prostate and bladder cancer, and surgical interventions for benign prostatic hyperplasia (BPH). He specializes in clinical trials, patient-reported outcomes, and the application of advanced imaging techniques such as MRI and PET/CT for cancer diagnosis and treatment planning.

Research Interests
Dr. Chalasani explores surgical techniques for BPH, management strategies for non-muscle-invasive bladder cancer, and active surveillance protocols in prostate cancer. His work emphasizes optimizing patient comfort during procedures (e.g., pain management during prostate biopsies) and improving diagnostic accuracy through multi-modal imaging approaches. He also investigates treatment disparities in low-risk prostate cancer management across Australia and New Zealand.

Publications Trends
Recent work highlights systematic reviews comparing surgical methods (e.g., endoscopic enucleation vs. TURP for BPH) and meta-analyses of preoperative assessments (e.g., cardiopulmonary testing before radical cystectomy). He has contributed to clinical trials such as the NMIBC-SI symptom index and the PRIMARY trial evaluating PET/CT in prostate cancer diagnosis.

Grants & Collaborations
He led the Pain-Free TRUS B trial (Cancer Australia grant) and contributed to the BCG+MMC trial for bladder cancer (ANZUP 1301). His collaborations span academic institutions and clinical networks, focusing on translating research into evidence-based urological practice.